Gene editing tool shows promise in treating Huntington's disease in mice

Researchers at the University of Illinois Urbana‑Champaign have demonstrated that a gene‑editing tool can precisely rewrite the mutation responsible for Huntington’s disease, leading to a marked reduction in toxic protein fragments and associated symptoms in a mouse model. The study, which focused on the huntingtin gene, employed a targeted approach to correct the expanded CAG repeat that drives the disease’s progression.

In treated mice, the edited gene produced lower levels of the abnormal protein fragments that accumulate in the brain, and the animals displayed fewer motor deficits and improved cognitive performance compared to untreated controls. The findings suggest that precise genome editing can mitigate the cellular and behavioral hallmarks of Huntington’s disease, offering a promising avenue for future therapeutic development.

While the work remains preclinical, the results underscore the potential of gene‑editing technologies to correct pathogenic mutations directly and highlight the importance of continued research into safe, effective delivery methods for human patients.